Retatrutide - Hubio Pharm
CLASSIFICATION Triple agonist peptide, GIP receptor and GLP-1 receptor
MANUFACTURER Hubio Pharm
LAB TEST See Document
WAREHOUSE USA Warehouse 7
SUBSTANCE Retatrutide,
Retatrutide is a breakthrough peptide for weight management and body transformation. Unlike semaglutide (GLP-1 only) or tirzepatide (GLP-1 + GIP), Retatrutide targets three receptors at once — GLP-1, GIP, and glucagon. This triple action delivers stronger appetite control, faster fat loss, better glucose regulation, and increased energy expenditure, making it one of the most advanced options available.
Retatrutide – triple-action peptide (GLP-1 + GIP + glucagon), more powerful than semaglutide or tirzepatide for weight loss and metabolic support.
Related Products
Reviews
There are no reviews yet.